Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine effects on sufentanil ED50 in patient-controlled analgesia after cesarean section
ChiCTR2000041302Phase 4Recruiting
- Sponsor
- Nanchong City Central Hospital
- Start
- Jan 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexmedetomidine and sufentanil in postoperative pain (2 arms), sponsored by Nanchong City Central Hospital. Primary endpoints: Pain score and Sufentanil dosage. Started Jan 2021; status: recruiting.
02
Drugs
dexmedetomidinesufentanil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2000041302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000041302.